Blood Sugar Molecules Called Glycans May Predict and Reverse Biological Aging
A 20,000-person study finds IgG glycan patterns track biological aging, predict mortality, and shift toward youth with interventions.
18 articles
A 20,000-person study finds IgG glycan patterns track biological aging, predict mortality, and shift toward youth with interventions.
A comprehensive 2025 review covers GBS diagnosis, ICU management, immunotherapy, and emerging biomarkers for intensivists.
A new perspective outlines how stem cells, bioprinted organs, and cross-species genes could replace β not just repair β aging biology.
Randomized trial finds therapeutic plasma exchange improves lab values but doesn't reduce 30-day mortality in acute liver failure patients.
Review reveals critical differences between congenital and immune-mediated thrombotic thrombocytopenic purpura in children.
Comprehensive review reveals therapeutic plasma exchange may improve survival and organ function in sepsis patients through multiple mechanisms.
Therapeutic plasma exchange successfully reduced soluble mesothelin levels by 44%, potentially restoring cancer drug effectiveness.
Comprehensive review reveals TPE could shift from reactive treatment to preventative therapy for cardiovascular, metabolic, and neurological aging.
Multi-center study reveals therapeutic plasma exchange may improve survival in severe amatoxin poisoning cases.
Therapeutic plasma exchange emerges as potential treatment for severe postural tachycardia syndrome with autoimmune features.
Scientists use kidney organoids to test patient plasma and predict focal segmental glomerulosclerosis recurrence after transplant.
Comprehensive review reveals breakthrough approaches to managing deadly liver failure syndrome with improved transplant outcomes.
Meta-analysis of 5,336 patients shows therapeutic plasma exchange significantly improves survival in acute-on-chronic liver failure.
Once nearly fatal, thrombotic thrombocytopenic purpura now has 95% survival rates through targeted treatments and early diagnosis advances.
First controlled study shows therapeutic plasma exchange safely reduces biological age markers across multiple molecular pathways.
Yale researcher who developed PhenoAge discusses epigenetic aging clocks and interventions that could slow biological aging processes.
Dr. Khanh Nguyen reveals how young plasma infusions and therapeutic plasma exchange are revolutionizing anti-aging medicine.
Dr. Khanh Nguyen reveals cutting-edge plasma exchange therapies and stem cell protocols only available in Texas.